Quick Answer
Enveric Biosciences, Inc. reported Total Revenue of $39.91 million for fiscal year 2019.
Enveric Biosciences, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2019 | $39.91M | -7.2% |
| 2018 | $43.00M | -11.5% |
| 2017 | $48.59M | +34.4% |
| 2016 | $36.15M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2020 | $8.48M | -7.3% | +2.8% |
| June 30, 2020 | $8.25M | -25.1% | -14.0% |
| March 31, 2020 | $9.60M | -10.1% | +5.0% |
| September 30, 2019 | $9.15M | -13.5% | -16.9% |
| June 30, 2019 | $11.02M | -0.5% | +3.1% |
| March 31, 2019 | $10.69M | -3.4% | +1.0% |
| September 30, 2018 | $10.58M | -15.6% | -4.5% |
| June 30, 2018 | $11.08M | -9.7% | +0.1% |
- Enveric Biosciences, Inc. showed a decrease of -7.2% in Total Revenue compared to the prior fiscal year.
- Over the 2016–2019 period, Enveric Biosciences, Inc.’s total revenue has grown by 10.4% (from $36.15 million to $39.91 million).
- The most recent figure is from Enveric Biosciences, Inc.’s fiscal year 2019 report (Form 10-K), filed with the SEC on March 25, 2020.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: